{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:44:19Z","timestamp":1774712659741,"version":"3.50.1"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2013,11,1]]},"DOI":"10.5414\/cp201852","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T10:48:21Z","timestamp":1379414901000},"page":"823-831","source":"Crossref","is-referenced-by-count":27,"title":["One year long-term study on abuse liability of nalfurafine in hemodialysis patients"],"prefix":"10.5414","volume":"51","author":[{"given":"Yuji","family":"Ueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoji","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T10:40:51Z","timestamp":1382611251000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=10871&doi=10.5414\/CP201852&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"alternative-id":["201852"],"URL":"https:\/\/doi.org\/10.5414\/cp201852","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,1]]}}}